Drug Repositioning in Oncology
Conclusions:
Therefore, drug repositioning represents a promising alternative for the treatment of oncological disorders; however, the support from funding agencies and from the government is still needed, the latter regarding regulatory issues.
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Therapeutic Opinion Source Type: research
More News: Aspirin | Cancer | Cancer & Oncology | Captopril | Celebrex | Clinical Trials | Drugs & Pharmacology | Immunotherapy | Methotrexate | Norvir | Reclast | Sertraline | Study | Zoloft | Zometa